Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;49(5):404-408.
doi: 10.1111/jop.12999. Epub 2020 Feb 9.

Clinical manifestations of oral proliferative verrucous leukoplakia: A systematic review

Affiliations

Clinical manifestations of oral proliferative verrucous leukoplakia: A systematic review

Aina Torrejon-Moya et al. J Oral Pathol Med. 2020 May.

Abstract

Objective: The aim of this systematic review was to gather the available evidence about proliferative verrucous leukoplakia. This systematic review was conducted to answer the question: "What are the main clinical features of PVL patients?".

Material and methods: A systematic review of the literature was done following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements. An electronic research was carried out using different electronic databases; PubMed, and Scopus. Inclusion criteria were papers which reported at least 10 patients with proliferative verrucous leukoplakia and were published not more than 10 years ago.

Results: A total of 285 records were identified through databases, although only 6 of them were eligible. Most patients were women, above 60 years of age (67.4). Additionally, 28 of them were non-smokers (66.6%) and 24 were non-habitual drinkers (57.1%). The most common locations were gingiva (50.9%), buccal mucosa (44.9%), and tongue (40.6%) CONCLUSION: Level C can be established to conclude the proliferative verrucous leukoplakia demographic data, risk factors, malignant transformation, and location. A strict follow-up on these patients should be mandatory, even after surgical management since they have a high recurrence rate and a malignant transformation.

Keywords: proliferative verrucous leukoplakia; treatment.

PubMed Disclaimer

References

REFERENCES

    1. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; Terminology, classification and present concepts of management. Oral Oncol. 2009;45:317-323.
    1. Staines K, Rogers H. Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners. Br Dent J. 2017;223(9):655-661.
    1. World Health Organization. Pathology and Genetics of Head and Neck Tumors. IARC. 2017.
    1. van der Waal I, Reichart PA. Oral proliferative verrucous leukoplakia revisited. Oral Oncol. 2008;44:719-721.
    1. López-Jornet P, Alonso FC. Proliferative verrucous leukoplakia and malignant transformation. J Eur Acad Dermatol Venereol. 2008;22:1138-1139.

Publication types

LinkOut - more resources